BRIEF published on 11/20/2025 at 15:56, 9 months 21 days ago Le groupe Vanguard révèle sa participation dans Qualcomm Titres Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Qualcomm
BRIEF published on 11/20/2025 at 15:55, 9 months 21 days ago The Vanguard Group's Disclosure on American Axle & Manufacturing Holdings, Inc. Form 8.3 The Vanguard Group Securities Disclosure Stock Transactions American Axle & Manufacturing
BRIEF published on 11/20/2025 at 15:55, 9 months 21 days ago Déclaration du groupe Vanguard concernant American Axle & Manufacturing Holdings, Inc. Transactions Boursières Le Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières American Axle & Manufacturing
BRIEF published on 11/20/2025 at 15:53, 9 months 21 days ago The Vanguard Group Discloses Position in JTC plc Takeover Code Securities Disclosure Vanguard Group Financial Holdings JTC Plc
BRIEF published on 11/20/2025 at 15:53, 9 months 21 days ago Le groupe Vanguard révèle sa participation dans JTC plc Groupe Vanguard Actifs Financiers Code De Prise De Contrôle JTC Plc Informations Sur Les Valeurs Mobilières
BRIEF published on 11/20/2025 at 15:51, 9 months 21 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
BRIEF published on 11/20/2025 at 15:51, 9 months 21 days ago Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Avadel Pharmaceuticals Panel Irlandais Des OPA
BRIEF published on 11/20/2025 at 15:50, 9 months 21 days ago The Vanguard Group Discloses Position in Mural Oncology plc Form 8.3 Vanguard Group Shareholding Irish Takeover Mural Oncology
BRIEF published on 11/20/2025 at 15:50, 9 months 21 days ago Le groupe Vanguard révèle sa participation dans Mural Oncology plc Actionnariat Groupe Vanguard Formulaire 8.3 Prise De Contrôle Irlandaise Oncologie Murale
BRIEF published on 11/20/2025 at 15:49, 9 months 21 days ago The Vanguard Group Discloses Position in Greencore Group Securities Disclosure Takeover Code Vanguard Group Greencore Group
Published on 09/11/2026 at 17:00, 12 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 12 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 1 hour 47 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 2 hours 12 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 2 hours 42 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 16:30, 42 minutes ago Belt and Road Summit in Hong Kong welcomes over 6,200 global leaders to explore new business opportunities
Published on 09/11/2026 at 16:00, 1 hour 12 minutes ago Deutsche Postbank Funding Trust III published semi-annual report
Published on 09/11/2026 at 16:00, 1 hour 12 minutes ago Form 8.3 - IPConcept (Luxemburg) S.A.: SONNTAG Premium
Published on 09/11/2026 at 15:29, 1 hour 43 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/11/2026 at 15:24, 1 hour 48 minutes ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC
Published on 09/11/2026 at 07:00, 10 hours 12 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 10 hours 12 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 10 hours 12 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 10 hours 12 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 21 hours 42 minutes ago Availability of the 2026 Interim Financial Report
